Large-scale testing (Phase 3)UnknownNCT00454389What this trial is testingStrontium90 Beta Radiation With Lucentis to Treat Age-Related Macular DegenerationWho this might be right forMacular Degeneration NeoVista 494
Not applicableEnded earlyNCT00001310What this trial is testingTissue Studies of Human Eye DiseasesWho this might be right forRetinal DiseaseCorneal DiseaseDiabetic Retinopathy+2 more National Eye Institute (NEI) 3,833
Not applicableStudy completedNCT01914380What this trial is testingInvestigating the Effectiveness of Eylea in Patients With Wet Age-related Macular DegenerationWho this might be right forWet Age-related Macular Degeneration Bayer 988
Large-scale testing (Phase 3)Study completedNCT04964089What this trial is testingEvaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration Kodiak Sciences Inc 557
Early research (Phase 1)Study completedNCT04747197What this trial is testingFirst in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration EyePoint Pharmaceuticals, Inc. 17
Not applicableStudy completedNCT01258335What this trial is testingOmega-3-fatty Acids on Age-related MacularWho this might be right forAged Macular Degeneration Mid Atlantic Retina 25
Testing effectiveness (Phase 2)Study completedNCT03558074What this trial is testingEvaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular DegenerationWho this might be right forWet Age-related Macular Degeneration Alkahest, Inc. 26
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368What this trial is testingEvaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKWho this might be right forWet Age-related Macular Degeneration Kodiak Sciences Inc 675
Testing effectiveness (Phase 2)Ended earlyNCT01122511What this trial is testingSafety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular DegenerationWho this might be right forSubfoveal Choroidal NeovascularizationAge-Related Maculopathy Allergan 4
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804What this trial is testingLong Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular NeovascularizationWho this might be right forAge-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor Kim's Eye Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04746963What this trial is testingSafety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) AsclepiX Therapeutics, Inc. 3
Early research (Phase 1)Study completedNCT04989699What this trial is testingStudy Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Ocular Therapeutix, Inc. 21
Post-approval studies (Phase 4)UnknownNCT01669447What this trial is testingEvaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisWho this might be right forDegeneration of Macula and Posterior Pole Osias Francisco de Souza 20
Early research (Phase 1)Study completedNCT05639530What this trial is testingA Dose Escalation Study of IBI333 in Subjects With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Innovent Biologics (Suzhou) Co. Ltd. 17
Not applicableLooking for participantsNCT06604104What this trial is testingVisual Frailty in AgeingWho this might be right forFrailtyAge-Related Macular DegenerationFunctional Status+5 more University of Edinburgh 20
Testing effectiveness (Phase 2)Ended earlyNCT03869684What this trial is testingAssess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Senju Pharmaceutical Co., Ltd. 13
Post-approval studies (Phase 4)Ended earlyNCT00134667What this trial is testingMacugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)Who this might be right forAge-Related Macular Degeneration Eyetech Pharmaceuticals 360
Not applicableUnknownNCT05259371What this trial is testingStudy of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-related Macular DegenerationWho this might be right forEarly to Moderate Dry Age-Related Macular Degeneration Nu Eyne Co., Ltd. 25
Not applicableWithdrawnNCT04045704What this trial is testingCataract Surgery on Advanced Age Related Macular Degeneration PatientsWho this might be right forCataractMacular Degeneration Advanced University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT04993352What this trial is testingEvaluate the Safety and Efficacy of HLX04-O in Subjects With wAMDWho this might be right forAge Related Macular Degeneration Shanghai Henlius Biotech 20